Mallinckrodt Presents Latest Health Economics Data on Acthar® Gel (Repository Corticotropin Injection) at the Academy of Managed Care Pharmacy (AMCP) Nexus 2023
— Findings from two health economics analyses of Acthar Gel provide further insight into its cost-effectiveness as a treatment option for advanced symptomatic sarcoidosis,1 and its impact on clinical, economic, and real-world outcomes in patients with nephrotic syndrome2 — DUBLIN, Oct. 26, 2023 /PRNewswire/ — Mallinckrodt plc (OTCMKTS: MNKTQ), a global specialty pharmaceutical company, recently shared … Read more